Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Dalcor Pharmaceuticals

Clinical trials sponsored by Dalcor Pharmaceuticals, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • Gene-Targeted drug aims to prevent second heart attacks Results expected Aug 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1
Sort by
  • Gene-Targeted drug aims to prevent second heart attacks

    Disease control Recruiting now

    This phase 3 trial tests whether the drug dalcetrapib can reduce the risk of major heart problems like heart attacks in people who have a specific genetic makeup (AA genotype) and have recently had a heart-related event. About 2,000 participants will receive either dalcetrapib or…

    Phase 3 • Sponsor: DalCor Pharmaceuticals • Aim: Disease control

    Last updated Jun 27, 2026 14:01 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space